5 reports

Patients were randomized in a ##:## fashion to active drug versus placebo.

  • Allergy
  • Allergy Immunotherapy
  • Immunotherapy
  • Therapy
  • Company

THE DRUG CANDIDATE ACTS BY TARGETING DIPEPTIDASE-##.

  • Allergy
  • Antifungal
  • Blood Disease
  • Immunotherapy
  • Company

THE DRUG CANDIDATE IS A ## MER PEPTIDE ACTS BY TARGETING PROGRAMMED CELL DEATH ## LIGAND ## (PD-L##).

  • Allergy
  • Cell Therapy
  • Immunotherapy
  • Company
  • Bristol-Myers Squibb Company

Two out of the six were considered possibly related to study drug: one in Group ## and one in Group ##.

  • Allergy
  • Antifungal
  • Immunotherapy
  • Company
  • SCYNEXIS, Inc.

THE DRUG CANDIDATE IS IN PHASE II STAGE FOR PEANUT ALLERGY IN ADULTS AND PEDIATRICS, GRASS POLLEN ALLERGY AND DERMATITIS GLOBALLY.

  • Allergy
  • Antifungal
  • Clinical Trial
  • Immunotherapy
  • Company